Current Drug Targets
Title: Editorial [ Hot Topic: Wnt Signaling (Guest Editor: Rashna D. Balsara) ]
Volume: 9 Issue: 7
Author(s): Rashna D. Balsara
Affiliation:
Export Options
About this article
Cite this article as:
Balsara D. Rashna, Editorial [ Hot Topic: Wnt Signaling (Guest Editor: Rashna D. Balsara) ], Current Drug Targets 2008; 9 (7) . https://dx.doi.org/10.2174/138945008784911804
DOI https://dx.doi.org/10.2174/138945008784911804 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
13
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities
Current Pharmaceutical Design Preclinical Evaluation of New Taxoids
Current Pharmaceutical Design Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets P-glycoprotein Inhibition: The Past, the Present and the Future
Current Drug Metabolism Natural Products as a Source of Protein Kinase Activators and Inhibitors
Current Topics in Medicinal Chemistry Thapsigargin, Origin, Chemistry, Structure-Activity Relationships and Prodrug Development
Current Pharmaceutical Design Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Genitourinary Tract Tumors in Children: An Update
Current Pediatric Reviews Epigenetic Regulation and Therapeutic Approaches in Cancer
Current Topics in Medicinal Chemistry Regulation of HIPK Proteins by MicroRNAs
MicroRNA Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets microRNAs and Esophageal Cancer - Implications for Pathogenesis and Therapy
Current Pharmaceutical Design The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Current Cancer Drug Targets Application of 3-methylene- and 3-(monosubstituted)alkylideneoxindoles in the Synthesis of Heterocyclic Compounds
Current Organic Chemistry Potentiating Effect of Ethnomedicinal Plants Against Proliferation on Different Cancer Cell Lines
Current Drug Metabolism Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives
Current Pharmaceutical Design p53-Induced Apoptosis and Inhibitors of p53
Current Medicinal Chemistry Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling
Anti-Cancer Agents in Medicinal Chemistry Relevance of Micrometastases and Targeting the Bone Marrow Niche with Zoledronic Acid in Breast Cancer
Current Cancer Therapy Reviews